comparemela.com

Azenta (NASDAQ:AZTA – Get Free Report)‘s stock had its “equal weight” rating reiterated by Stephens in a report issued on Tuesday, Benzinga reports. They presently have a $55.00 target price on the stock. Stephens’ price objective suggests a potential upside of 15.04% from the company’s current price. Several other analysts also recently commented on the […]

Related Keywords

China ,United States ,America ,Asia Pacific ,Raymond James ,Life Sciences Services ,Life Sciences Products ,Cubist Systematic Strategies ,Needham Company ,Azenta Inc ,Millennium Management ,Azenta Company Profile ,Get Free Report ,North America ,Life Sciences ,Azenta Daily ,Azenta ,Nasdaq Azta ,Azta ,Medical ,Reiterated Rating ,Stephens ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.